Anti-metastatic effect of taraxasterol on prostate cancer cell lines

Morteza Movahhed , Mona Pazhouhi, Hadi Esmaeili Gouvarchin Ghaleh, Bahman Jalali Kondori

Abstract


Background and purpose: Prostate cancer is the second cause of death among men. Nowadays, treating various cancers with medicinal plants is more common than other therapeutic agents due to their minor side effects. This study aimed to evaluate the effect of taraxasterol on the prostate cancer cell line.

Experimental approach: The prostate cancer cell line (PC3) was cultured in a nutrient medium. MTT method and trypan blue staining were used to evaluate the viability of cells in the presence of different concentrations of taraxasterol, and IC50 was calculated. Real-time PCR was used to measure the expression of MMP-9,                 MMP-2, uPA, uPAR, TIMP-2, and TIMP-1 genes. Gelatin zymography was used to determine MMP-9 and MMP-2 enzyme activity levels. Finally, the effect of taraxasterol on cell invasion, migration, and adhesion was investigated.

Findings/Results: Taraxasterol decreased the survival rate of PC3 cells at IC50 time-dependently (24, 48, and 72 h). Taraxasterol reduced the percentage of PC3 cell adhesion, invasion, and migration by 74, 56, and                       76 percent, respectively. Real-time PCR results revealed that uPA, uPAR, MMP-9, and MMP-2 gene expressions decreased in the taraxasterol-treated groups, but TIMP-2 and TIMP-1 gene expressions increased significantly. Also, a significant decrease in the level of MMP-9 and MMP-2 enzymes was observed in the PC3 cell line treated with taraxasterol.

Conclusion and implications: The present study confirmed the therapeutic role of taraxasterol in preventing prostate cancer cell metastasis in the in-vitro study.

Keywords


MMP-2; MMP-9; PC3 cell; Prostate cancer; Taraxasterol.

Full Text:

PDF

References


Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. DOI: 10.3322/caac.21660.

Ellinger J, Alajati A, Kubatka P, Giordano FA, Ritter M, Costigliola V, et al. Prostate cancer treatment costs increase more rapidly than for any other cancer-how to reverse the trend? EPMA J. 2022;13(1):1-7. DOI: 10.1007/s13167-022-00276-3.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA CA Cancer J Clin. 2018;68(6):394-424. DOI: 10.3322/caac.21492

Elmehrath AO, Afifi AM, Al-Husseini MJ, Saad AM, Wilson N, Shohdy KS, et al. Causes of death among patients with metastatic prostate cancer in the US from 2000 to 2016. JAMA Netw Open. 2021;4(8):e2119568,1-11. DOI: 10.1001/jamanetworkopen.2021.19568

Stranne J, Brasso K, Brennhovd B, Johansson E, Jäderling F, Kouri M, et al. SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer. Scand J Urol. 2018;52(5-6):313-320. DOI: 10.1080/21681805.2018.1520295.

Bagshaw HP, Arnow KD, Trickey AW, Leppert JT, Wren SM, Morris AM. Assessment of second primary cancer risk among men receiving primary radiotherapy vs surgery for the treatment of prostate cancer.JAMA Netw Open. 2022;5(7):e2223025,1-12. DOI: 10.1001/jamanetworkopen.2022.23025.

Mukhtar E, Adhami VM, Mukhtar H. Targeting microtubules by natural agents for cancer therapymicrotubule-targeting agents for cancer chemotherapy. Mol Cancer Ther. 2014;13(2): 275-284. DOI: 10.1158/1535-7163.MCT-13-0791.

Guo Q, Dong Y, Zhang Y, Fu H, Chen C, Wang L, et al. Sequential release of pooled siRNAs and paclitaxel by aptamer-functionalized shell-core nanoparticles to overcome paclitaxel resistance of prostate cancer. ACS Appl. Mater Interfaces. 2021;13(12):13990-4003.DOI: 10.1021/acsami.1c00852.

Shaik BB, Katari NK, Jonnalagadda SB. Role of natural products in developing novel anticancer agents: a perspective. Chem Biodivers. 2022;19(11):e202200535,1-13.DOI: 10.1002/cbdv.202200535.

Zhang D, Kanakkanthara A. Beyond the paclitaxel and vinca alkaloids: next generation of plant-derived microtubule-targeting agents with potential anticancer activity. Cancers (Basel). 2020;12(7):1721,1-23. DOI: 10.3390/cancers12071721.

Akbari B, Baghaei‐Yazdi N, Bahmaie M, Mahdavi Abhari F. The role of plant‐derived natural antioxidants in reduction of oxidative stress. Biofactors. 2022;48(3):611-633. DOI: 10.1002/biof.1831.

Khazaei M, Pazhouhi M. Protective effect of hydroalcoholic extracts of Trifolium pratense L. on pancreatic β cell line (RIN-5F) against cytotoxicty of streptozotocin. Res Pharm Sci. 2018;13(4):324-331.DOI: 10.4103/1735-5362.235159

Lis B, Olas B. Pro-health activity of dandelion (Taraxacum officinale L.) and its food products-history and present. J Funct Foods. 2019;59:40-48. DOI: 10.1016/j.jff.2019.05.012

Kour J, Sharma R, Nayik GA, Ramaiyan B, Sofi SA, Alam MS, et al. Dandelion. In: Nayik GA, Gull A, editors. Antioxidants in vegetables and nuts-properties and health benefits. Springer: Singapore; 2020. P. 237. DOI: 10.1007/978-981-15-7470-2.

Mir MA, Sawhney S, Jassal M. In-vitro antidiabetic studies of various extracts of Taraxacum officinale. Pharma Innov J. 2015;4(1):61-66.

Li H, Sang R, Zhao X, Li C, Wang W, Wang M, et al. Research Note: Taraxasterol alleviates aflatoxin B1-induced oxidative stress in chicken primary hepatocytes. Poult Sci. 2023:102(1):102286,1-5.DOI: 10.1016/j.psj.2022.102286.

Sang R, Yu Y, Ge B, Xu L, Wang Z, Zhang X. Taraxasterol from Taraxacum prevents concanavalin A-induced acute hepatic injury in mice via modulating TLRs/NF-κB and Bax/Bc1-2 signalling pathways. Artif Cells Nanomed Biotechnol. 2019;47(1):3929-3937. DOI: 10.1080/21691401.2019.1671433.

Bao T, Ke Y, Wang Y, Wang W, Li Y, Wang Y, et al. Taraxasterol suppresses the growth of human liver cancer by upregulating Hint1 expression. J Mol Med. 2018;96(7):661-672. DOI: 10.1007/s00109-018-1652-7.

Kamal FZ, Lefter R, Mihai CT, Farah H, Ciobica A, Ali A, et al. Chemical composition, antioxidant and antiproliferative activities of Taraxacum officinale essential oil. Molecules. 2022;27(19):6477,1-18.DOI: 10.3390/molecules27196477.

Liu T, Zhou L, Li D, Andl T, Zhang Y. Cancer-associated fibroblasts build and secure the tumor microenvironment. Front Cell Dev Biol. 2019;7: 60,1-58.DOI: 10.3389/fcell.2019.00060.

Azevedo Martins JM, Rabelo-Santos SH, do Amaral Westin MC, Zeferino LC. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis. BMC Cancer. 2020;20(1):660,1-11.DOI: 10.1186/s12885-020-07150-3.

Hsieh SL, Hsieh S, Lai PY, Wang JJ, Li CC, Wu CC. Carnosine suppresses human colorectal cell migration and intravasation by regulating EMT and MMP expression. Am J Chin Med. 2019;47(2):477-494.DOI: 10.1142/S0192415X19500241.

Rajasinghe LD, Pindiprolu RH, Gupta SV. Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion via the inhibition of NF-κB, uPA activator, and MMP-9. OncoTargets Ther. 2018;11:4301-4314.DOI: 10.2147/OTT.S160163.

Zamir-Nasta T, Abbasi A, Kakebaraie S, Ahmadi A, Pazhouhi M, Jalili C. Aflatoxin G1 exposure altered the expression of BDNF and GFAP, histopathological of brain tissue, and oxidative stress factors in male rats. Res Pharm Sci . 2022;17(6):677-685.DOI: 10.4103/1735-5362.359434.

Kim C, Kim B. Anti-cancer natural products and their bioactive compounds inducing ER stress-mediated apoptosis: a review. Nutrients. 2018;10(8):1021,1-29. DOI: 10.3390/nu10081021.

Zhang Y, Li H, Zhang J, Zhao C, Lu S, Qiao J, et al. The combinatory effects of natural products and chemotherapy drugs and their mechanisms in breast cancer treatment. Phytochem Rev. 2020;19(5): 1179-1197. DOI: 10.1007/s11101-019-09628-w.

Duffy M, McGowan P, Gallagher W. Cancer invasion and metastasis: changing views. J Pathol. 2008;214(3):283-293. DOI: 10.1002/path.2282.

Zhang X, Xiong H, Liu L. Effects of taraxasterol on inflammatory responses in lipopolysaccharide-induced RAW 264.7 macrophages. J Ethnopharmacol. 2012;141(1):206-211.DOI: 10.1016/j.jep.2012.02.020.

Menke K, Schwermer M, Felenda J, Beckmann C, Stintzing F, Schramm A, et al. Taraxacum officinale extract shows antitumor effects on pediatric cancer cells and enhance mistletoe therapy. Complement Ther Med. 2018;40:158-164. DOI: 10.1016/j.ctim.2018.03.005.

Man J, Wu L, Han P, Hao Y, Li J, Gao Z, et al. Revealing the metabolic mechanism of dandelion extract against A549 cells using UPLC‐QTOF MS. Biomed Chromatogr. 2022;36(3):e5272. DOI: 10.1002/bmc.5272

Li C, Zheng Z, Xie Y, Zhu N, Bao J, Yu Q, et al. Protective effect of taraxasterol on ischemia/reperfusion-induced acute kidney injury via inhibition of oxidative stress, inflammation, and apoptosis. Int Immunopharmacol. 2020;89:107169.DOI: 10.1016/j.intimp.2020.107169.

Song Z, Wang J, Su Q, Luan M, Chen X, Xu X. The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma. Braz J Otorhinolaryngol. 2021;87(5):521-528.DOI: 10.1016/j.bjorl.2019.10.009.

Pan Q, Yuan T, Ding Q. Clinical value of matrix metalloproteinase-2 and-9 in ultrasound-guided radiofrequency ablation treatment for papillary thyroid carcinoma. J Int Med Res. 2020;48(8):0300060520917581,1-10.DOI: 10.1177/0300060520917581.

Mohammadi F, Javid H, Afshari AR, Mashkani B, Hashemy SI. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression. Mol Biol Rep. 2020;47(6):4263-4272. DOI: 10.1007/s11033-020-05532-1.

Figueira R, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer. 2009;9(1):20,1-11. DOI: 10.1186/1471-2407-9-20.

Wang ZD, Huang C, Li ZF, Yang J, Li BH, Liang RR, et al. Chrysanthemum indicum ethanolic extract inhibits invasion of hepatocellular carcinoma via regulation of MMP/TIMP balance as therapeutic target. Oncol Rep. 2010;23(2):413-421. DOI: 10.3892/or_00000650.

Jaiswal RK, Varshney AK, Yadava PK. Diversity and functional evolution of the plasminogen activator system. Biomed Pharmacother. 2018;98:886-898. DOI: 10.1016/j.biopha.2018.01.029.

Ismail AA, Shaker BT, Bajou K. The Plasminogen-activator plasmin system in physiological and pathophysiological angiogenesis. Int J Mol Sci. 2021;23(1):337,1-19. DOI: 10.3390/ijms23010337.

Liu H, Zeng Z, Wang S, Li T, Mastriani E, Li QH, et al. Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9. Cancer Biol Ther. 2017;18(12):990-999. DOI: 10.1080/15384047.2017.1394542.

Bi Q, Wang M, Zhao F, Wang M, Yin X, Ruan J, et al. N-Butanol fraction of Wenxia formula extract inhibits the growth and invasion of non-small cell lung cancer by down-regulating Sp1-mediated MMP2 expression. Front. Pharmacol. 2020;11:594744,1-10. DOI: 10.3389/fphar.2020.594744.

Zhu J, Li X, Zhang S, Liu J, Yao X, Zhao Q, et al. Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling. Hum Exp Toxicol. 2021;40(12_suppl):S87-S95. DOI: 10.1177/09603271211023792.

Chen W, Li J, Li C, Fan HN, Zhang J, Zhu JS. Network pharmacology-based identification of the antitumor effects of taraxasterol in gastric cancer. Int J Immunopathol Pharmacol. 2020;34:2058738420933107,1-6. DOI: 10.1177/2058738420933107

Zhao L, Niu H, Liu Y, Wang L, Zhang N, Zhang G, et al. LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells. J Cancer. 2019;10(26):6481-6490. DOI: 10.7150/jca.33223.

Hingorani DV, Lippert CN, Crisp JL, Savariar EN, Hasselmann JP, Kuo C, et al. Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage. PloS One. 2018;13(9):e0198464,1-17.DOI: 10.1371/journal.pone.0198464.

Kiani A, Kamankesh M, Vaisi-Raygani A, Moradi MR, Tanhapour M, Rahimi Z, et al. Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer. Mol Biol Rep. 2020;47(12):9373-9383. DOI: 10.1007/s11033-020-05968-5.

Mandlik DS, Mandlik SK. Herbal and natural dietary products: upcoming therapeutic approach for prevention and treatment of hepatocellular carcinoma. Nutr Cancer. 2021;73(11-12): 2130-2154. DOI: 10.1080/01635581.2020.1834591.

Tsai CF, Chen JH, Chang CN, Lu DY, Chang PC, Wang SL, et al. Fisetin inhibits cell migration via inducing HO-1 and reducing MMPs expression in breast cancer cell lines. Food Chem Toxicol. 2018;120:528-535. DOI: 10.1016/j.fct.2018.07.059.

Roca-Lema D, Martinez-Iglesias O, de Ana Portela CF, Rodríguez-Blanco A, Valladares-Ayerbes M, Díaz-Díaz A, et al. In vitro anti-proliferative and anti-invasive effect of polysaccharide-rich extracts from Trametes versicolor and Grifola frondosa in colon cancer cells. Int J Med Sci. 2019;16(2):231-240. DOI: 10.7150/ijms.28811.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.